10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35234063 | Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway. | 2022 Jan-Dec | 1 |
2 | 34247189 | Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis. | 2021 Aug | 1 |
3 | 29251327 | Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib. | 2018 Feb | 3 |
4 | 27959383 | Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway. | 2017 Jan | 2 |
5 | 28276433 | Renal cell carcinoma. | 2017 Mar 9 | 1 |
6 | 28687354 | Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition. | 2017 Oct 10 | 2 |
7 | 29207653 | Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy. | 2017 Oct 31 | 1 |
8 | 23434734 | The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. | 2013 Apr 15 | 3 |
9 | 23963659 | Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling. | 2013 Aug | 5 |
10 | 20054642 | Synergistic activity of letrozole and sorafenib on breast cancer cells. | 2010 Nov | 1 |